Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free

9 product images

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunocytochemistry/ Immunofluorescence analysis of JAR (Human placenta choriocarcinoma cell line) cells labeling Ubiquitin with Purified Anti-Ubiquitin antibody [EPR8830] ab134953 at 1:100 dilution (7.2μg/ml). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Cells were counterstained with Alexa Fluor® 594 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker ab195889 Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor^® 594) 1:200 (2.5 μg/ml). Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077 Goat anti rabbit IgG(Alexa Fluor^® 488) was used as the secondary antibody at 1:1000 dilution. DAPI nuclear counterstain. PBS instead of the primary antibody was used as the secondary antibody only control.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Rat liver tissue sections labeling Ubiquitin with Purified Anti-Ubiquitin antibody [EPR8830] ab134953 at 1:800 dilution (0.9 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH9. Tissue was counterstained with Hematoxylin. Goat Anti-Rabbit IgG H&L (HRP) ab97051 Goat Anti-Rabbit IgG H&L (HRP)
  secondary antibody was used at 1:500 dilution. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Mouse liver tissue sections labeling Ubiquitin with Purified Anti-Ubiquitin antibody [EPR8830] ab134953 at 1:800 dilution (0.9 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH9. Tissue was counterstained with Hematoxylin. Goat Anti-Rabbit IgG H&L (HRP) ab97051 Goat Anti-Rabbit IgG H&L (HRP)
  secondary antibody was used at 1:500 dilution. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of Human bladder carcinoma tissue sections labeling Ubiquitin with Purified Anti-Ubiquitin antibody [EPR8830] ab134953 at 1:800 dilution (0.9 μg/ml). Heat mediated antigen retrieval was performed using EDTA Buffer, pH9. Tissue was counterstained with Hematoxylin. Goat Anti-Rabbit IgG H&L (HRP) ab97051 Goat Anti-Rabbit IgG H&L (HRP) secondary antibody was used at 1:500 dilution. PBS instead of the primary antibody was used as the negative control.
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  This image is courtesy of an anonymous customer review.

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Anti-Ubiquitin antibody [EPR8830] ab134953 staining Ubiquitin in Mouse embryo tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed with formaldehyde and blocked with 1% FBS/BSA for 1 hour at room temperature; antigen retrieval was by heat mediation in citrate buffer, pH6. Samples were incubated with primary antibody (1/100 in 1% FBS/BSA) for 16 hours at 4°C. An undiluted HRP-conjugated Goat anti-rabbit IgG polyclonal was used as the secondary antibody.

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Flow Cytometry (Intracellular) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Overlay histogram showing HepG2 cells stained with Anti-Ubiquitin antibody [EPR8830] ab134953 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (Anti-Ubiquitin antibody [EPR8830] ab134953, 1/1000 dilution) for 30 min at 22�C. The secondary antibody used was Alexa Fluor^� 488 goat anti-rabbit IgG (H&L) (Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) ab150077) at 1/2000 dilution for 30 min at 22�C. Isotype control antibody (black line) was rabbit IgG (monoclonal) (0.1�g/1x10⁶ cells) used under the same conditions. Unlabelled sample (blue line) was also used as a control. Acquisition of >5,000 events were collected using a 20mW Argon ion laser (488nm) and 525/30 bandpass filter. This antibody gave a positive signal in HepG2 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions. This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).
  

• 

  Immunocytochemistry/ Immunofluorescence - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunofluorescent staining of JAR cells labelling Ubiquitin using Anti-Ubiquitin antibody [EPR8830] ab134953 at 1/250 dilutionThis data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Immunohistochemical analysis of paraffin embedded Human breast carcinoma tissue labelling Ubiquitin with Anti-Ubiquitin antibody [EPR8830] ab134953 at 1/250 dilution This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).

• 

  Flow Cytometry (Intracellular) - Anti-Ubiquitin antibody [EPR8830] - BSA and Azide free (ab230145)

  Intracellular Flow Cytometry analysis of JAR (Human placenta choriocarcinoma cell line) cells labeling Ubiquitin with purified Anti-Ubiquitin antibody [EPR8830] ab134953 at 1/70 dilution (10 ug/ml) (red). Cells were fixed with 4% Paraformaldehyde. A Goat anti rabbit IgG (Alexa Fluor^� 488) secondary antibody was used at 1/2000 dilution. Isotype control - Rabbit monoclonal IgG (Black). Unlabeled control - Cell without incubation with primary antibody and secondary antibody (Blue).
  

  This data was developed using the same antibody clone in a different buffer formulation containing PBS, BSA, glycerol, and sodium azide (Anti-Ubiquitin antibody [EPR8830] ab134953).